Medgyn MTA-100
Thermal Ablation System
In 2019, WHO issued new guidelines for the use of thermal ablation for cervical pre-cancerous lesions. While they continue to recommend cryotherapy, the WHO has offered thermal ablation as an alternative method of treatment for specific environments.
MedGyn is pleased to announce its latest device: MedGyn’s MTA-100 Thermal Ablation System. The device is a portable, lightweight device for the treatment of pre-cancerous lesions optimized for 20, 40, or 60 second intervals of treatment.